The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according to a new RAND study.
CDC proposes new antibiotics policy aimed at reducing STIs
The Centers for Disease Control and Prevention is proposing a new policy aimed at dramatically reducing sexually transmitted infections in the United States. In a
October 2, 2023